# ZoBio \- Drug Discovery Technology

Generated by Yoast SEO v27.9, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [DEL Screening Services](https://zobio.com/del-screening-services/)
- [About ZoBio](https://zobio.com/about-zobio/)
- [DEL Capabilities Whitepaper](https://zobio.com/del-capabilities-whitepaper-2/)
- [Precision Hit Discovery Strategies ZoBio 2025](https://zobio.com/webinars/precision-hit-discovery-strategies-zobio-2025/)
- [Webinars](https://zobio.com/webinars/)

## Posts
- [EFMC\-ACSMEDI Medicinal Chemistry Frontiers 2026](https://zobio.com/recent-events/efmc-acsmedi-medicinal-chemistry-frontiers-2026/): Molecular glues are rapidly emerging as a transformative modality in drug discovery, enabling novel mechanisms to modulate protein function through stabilization of protein–protein interactions\. Yet discovering synthetic molecular glues de novo remains a major challenge, particularly due to the need to identify compounds that both engage a target and promote cooperative ternary complex formation\.
- [EUROMAR 2026](https://zobio.com/meetings/euromar-2026/):  
- [Therapeutic Frontiers in Medicine, Mechanisms and Modalities](https://zobio.com/geen-categorie/therapeutic-frontiers-in-medicine-mechanisms-and-modalities/): ZoBio is excited to attend TFMED 2026, a four\-day transdisciplinary conference dedicated to next\-generation therapeutic modalities, including molecular glues, PROTACs, nucleic acid\-based therapies, and cell\-based approaches\.

The meeting brings together researchers, clinicians, and industry experts, offering in\-depth scientific sessions, direct interaction with leading specialists, and valuable opportunities for networking and collaboration, with a strong focus on early\-career scientists\.
- [ZoBio Launches Comprehensive DEL Hit Discovery Service for Challenging Targets](https://zobio.com/news/zobio-launches-comprehensive-del-hit-discovery-service-for-challenging-targets/): \<b\>LEIDEN, NL\</b\> 
ZoBio, a boutique problem\-solving Contract Research Organization \(CRO\) specializing in early gene\-to\-lead discovery, today announced the launch of its comprehensive\.\.\.
- [SLAS Europe 2026](https://zobio.com/recent-events/slas-europe-2026/): Molecular glues are rapidly emerging as a transformative modality in drug discovery, enabling novel mechanisms to modulate protein function through stabilization of protein–protein interactions\. Yet discovering synthetic molecular glues de novo remains a major challenge, particularly due to the need to identify compounds that both engage a target and promote cooperative ternary complex formation\.

## Categories
- [Geen categorie](https://zobio.com/category/geen-categorie/)
- [News](https://zobio.com/category/news/)
- [Blog](https://zobio.com/category/blog/)
- [Cases](https://zobio.com/category/cases/)
- [Past events](https://zobio.com/category/recent-events/)

## Tags
- [ZoBio](https://zobio.com/tag/zobio/)
- [Discovery](https://zobio.com/tag/discovery/)

## Optional
- [Sitemap index](https://zobio.com/sitemap_index.xml)